What are the latest funding news in the mental health market? (October 2026)
Everything we know about the mental health market, in one place. Get our report whether you build or invest.
The latest mental health funding deals show investors concentrating on clinical care, specialist treatment models and the infrastructure used to manage patients.
Across the 12 latest qualifying rounds, companies raised approximately $251.4M, with funding ranging from about $1.7M to $65M.
Specialized models for autism, ADHD, eating disorders, youth psychiatry and behavioral-health management were especially visible in this funding cohort.
And if you want to better understand this new industry, you can download our pitch covering the mental health market.
Insights
- The 12 latest mental health funding deals represented approximately $251.4M in disclosed capital, showing that investors are still willing to fund both early clinical models and scaled behavioral-health platforms.
- Draig Therapeutics, Hi Rasmus and Good Mood alone raised about $157M, or roughly 62% of the total capital in this group, showing how strongly larger rounds shaped overall mental health funding.
- Eight of the 12 companies directly diagnose or treat patients, suggesting that recent mental health investment has favored care delivery over broad consumer wellness products.
- Another three companies, Hi Rasmus, Onos Health and Aisel Health, operate directly inside clinical mental-health workflows, bringing 11 of the 12 deals close to actual treatment delivery.
- Autism and ADHD attracted three specialized financings through Prosper Health, Hi Rasmus and Kantoko, which together accounted for more than $62M of disclosed funding.
- Youth mental health remained a meaningful investment theme, with Flourish Health and Handspring Health raising a combined $45M for higher-acuity and specialist care models.
- Early-stage mental health startups can still raise relatively small specialist rounds: Comestai, Aisel Health, Kantoko and Arab Therapy raised about $8.2M combined across pre-seed, seed and pre-Series A financings.
- The geographic mix is broad, but the United States remains prominent, with at least five companies focused primarily on U.S. patients, payers or health systems.
Written by the New Market Pitch teamWe track new markets so founders and investors can move faster. About us
In our report covering the mental health market, you will always find fresh funding data, taken straight from our own verified funding database.
Summary table of the latest funding deals in the mental health market as of October 2026
We define the mental health market as the set of services and products that diagnose, treat, or clinically manage mental and substance use disorders.
We include licensed providers, facilities, medications, and clinically validated digital tools that are used to assess or treat recognized mental and substance use conditions.
We exclude general wellness, self-help, fitness, and lifestyle products that aim to improve mood or wellbeing but are not used as formal clinical treatment.
| Name | When | Amount in $ | Round Type | Category |
|---|---|---|---|---|
| Good Mood | September 30, 2026 | ≈$42M | C+ / late-stage venture | Digital psychiatry & mental-health care provider |
| Prosper Health | September 15, 2026 | $10.03M | Series A extension / equity | Adult autism & ADHD diagnosis and therapy |
| Comestai | September 7, 2026 | ≈$1.7M | Pre-seed | Eating-disorder clinical care |
| Hi Rasmus | September 3, 2026 | $50M | Growth equity | ABA & behavioral-health clinical infrastructure |
| Onos Health | August 26, 2026 | $17M | Series A | Behavioral-health clinical intelligence |
| Aisel Health | August 19, 2026 | ≈$2.0M | Pre-seed | Psychiatric clinical operating system |
| Kantoko | August 13, 2026 | ≈$2.5M | Seed | ADHD diagnosis & treatment |
| Arab Therapy | August 11, 2026 | $2M | Pre-Series A | Licensed online psychotherapy |
| Precise Behavioral | July 29, 2026 | $14.2M | Venture / Series A | Enterprise psychiatry & behavioral-health services |
| Flourish Health | July 27, 2026 | $26M | Series A | High-acuity youth psychiatric care |
| Draig Therapeutics | July 14, 2026 | $65M | Series B | Psychiatric medicines & neuropsychiatric biotech |
| Handspring Health | July 8, 2026 | $19M | Series B | Youth virtual therapy |
All the latest funding deals in the mental health market as of October 2026
Good Mood raised about $42M in late September 2026.
When was it?
Good Mood's latest financing was publicly reported on September 30, 2026.
Who are they?
Good Mood, also known as Haoxinqing, operates a psychiatric-care ecosystem combining online consultations, prescriptions, clinics, digital therapeutics and clinical technology.
Geographical focus?
Good Mood primarily serves China today, while the latest financing is also intended to support international expansion.
Why do we include them in the mental health market?
Good Mood directly supports psychiatric assessment, diagnosis, prescriptions and ongoing treatment, placing the company in digital psychiatry and mental-health care delivery.
What is the company stage?
Good Mood is at the growth stage, with a large psychiatrist network, digital services, physical care infrastructure and several previous funding rounds.
How much did they raise?
Good Mood raised nearly RMB300M, equivalent to approximately $42M.
What round is it?
Good Mood's financing was reported locally as a C+ round, although some databases classify it as a Series D.
Why did they raise?
Good Mood raised the capital to develop AI products, strengthen its psychiatric-care infrastructure and expand internationally.
In our research about mental health care, we turn what is vague and complex into simple, useful visuals. Market maps like this one show you at a glance where every startup stands.
Prosper Health raised $10.03M in September 2026.
When was it?
Prosper Health's financing was publicly reported on September 15, 2026, after its SEC filing earlier that month.
Who are they?
Prosper Health provides virtual autism diagnostic assessments and specialist outpatient therapy for autistic and other neurodivergent adults.
Geographical focus?
Prosper Health focuses on adult patients across the United States.
Why do we include them in the mental health market?
Prosper Health provides clinical diagnosis and psychotherapy for autism, ADHD and related needs, placing it in specialist virtual behavioral-health care.
What is the company stage?
Prosper Health is at the PMF and early growth stage, with established virtual care delivery and significant previous funding.
How much did they raise?
Prosper Health raised approximately $10.03M in the latest equity financing.
What round is it?
Prosper Health's financing is commonly described as a Series A extension or Series A-II equity round.
Why did they raise?
Prosper Health did not publicly disclose a specific use of proceeds for this financing.
Comestai raised about $1.7M in September 2026.
When was it?
Comestai announced its pre-seed financing on September 7, 2026.
Who are they?
Comestai provides multidisciplinary online and in-person treatment for eating disorders through psychotherapy, medical care, nutritional support and clinical coordination.
Geographical focus?
Comestai is initially focused on patients in Italy through its digital and hybrid clinical model.
Why do we include them in the mental health market?
Comestai directly treats recognized eating disorders through specialist clinicians, placing the company in eating-disorder and specialty mental-health care.
What is the company stage?
Comestai is at the early PMF stage, with an operating care model but still at the pre-seed phase of commercialization.
How much did they raise?
Comestai raised €1.5M, equivalent to approximately $1.7M.
What round is it?
Comestai raised a pre-seed round.
Why did they raise?
Comestai raised the capital to expand its clinical and technology teams, develop its platform and increase access to eating-disorder treatment.
Hi Rasmus raised $50M in September 2026.
When was it?
Hi Rasmus announced the investment on September 3, 2026.
Who are they?
Hi Rasmus provides clinical software for ABA and multidisciplinary behavioral-health providers, covering treatment planning, clinical data, documentation, supervision and outcomes.
Geographical focus?
Hi Rasmus operates globally, serving more than 1,000 organizations across all 50 U.S. states and roughly 90 countries.
Why do we include them in the mental health market?
Hi Rasmus is purpose-built for the clinical delivery and management of ABA treatment, placing it in behavioral-health and autism-care infrastructure.
What is the company stage?
Hi Rasmus is at the profitable growth stage after scaling internationally before taking major institutional capital.
How much did they raise?
Hi Rasmus raised $50M.
What round is it?
Hi Rasmus received a growth equity minority investment rather than a conventional venture Series B.
Why did they raise?
Hi Rasmus raised the capital to expand go-to-market operations, enterprise deployments, product development, AI capabilities and clinical outcomes research.
In our market report about mental health care, we always try to gather several sources and make estimates that make sense, so you can work with solid numbers.
Onos Health raised $17M in August 2026.
When was it?
Onos Health announced its Series A on August 26, 2026.
Who are they?
Onos Health uses AI to analyze behavioral-health records so health plans can evaluate care quality, utilization and treatment pathways.
Geographical focus?
Onos Health focuses on U.S. commercial insurance, Medicare Advantage and Medicaid health plans.
Why do we include them in the mental health market?
Onos Health is built specifically around behavioral-health clinical records and treatment quality, placing it in mental-health clinical intelligence and payer infrastructure.
What is the company stage?
Onos Health is at the PMF and growth stage, with major health plans already using its platform.
How much did they raise?
Onos Health raised $17M.
What round is it?
Onos Health raised a Series A round.
Why did they raise?
Onos Health raised the capital to expand adoption among health plans and further develop its behavioral-health AI platform.
Aisel Health raised about $2M in August 2026.
When was it?
Aisel Health announced its pre-seed round on August 19, 2026.
Who are they?
Aisel Health builds a clinical operating system for psychiatry that structures interviews, documents and patient histories for psychiatric teams.
Geographical focus?
Aisel Health was founded in Copenhagen and is using the new funding to expand particularly into the United Kingdom.
Why do we include them in the mental health market?
Aisel Health is purpose-built for psychiatric assessment and clinical workflows, placing it in psychiatric clinical software and care infrastructure.
What is the company stage?
Aisel Health is at the pre-seed and early commercial rollout stage.
How much did they raise?
Aisel Health raised €1.7M, equivalent to approximately $2M.
What round is it?
Aisel Health raised a pre-seed round.
Why did they raise?
Aisel Health raised the capital to scale its psychiatry platform and expand into the UK market.
Kantoko raised about $2.5M in August 2026.
When was it?
Kantoko announced its seed financing on August 13, 2026.
Who are they?
Kantoko provides Australian adults with online ADHD assessment, diagnosis, treatment and long-term GP-led clinical care.
Geographical focus?
Kantoko currently focuses on adult ADHD care across Australia.
Why do we include them in the mental health market?
Kantoko directly diagnoses and treats ADHD, placing the company in specialist digital psychiatry and ADHD clinical care.
What is the company stage?
Kantoko is at the early PMF and growth stage, with thousands of patients already using the service.
How much did they raise?
Kantoko raised A$3.5M, equivalent to approximately $2.5M.
What round is it?
Kantoko raised a seed round.
Why did they raise?
Kantoko raised the capital to expand its clinician network, develop its platform and make ADHD treatment available to more Australian adults.
Our document detailing everything you need to know about mental health gets updated several times a month, so you always get the latest view of where things stand.
Arab Therapy raised $2M in August 2026.
When was it?
Arab Therapy announced its financing on August 11, 2026.
Who are they?
Arab Therapy provides Arabic-language online psychotherapy through licensed specialists, supported by clinically supervised AI tools and mental-health content.
Geographical focus?
Arab Therapy serves Arabic-speaking populations, with a particular focus on Saudi Arabia and the wider MENA region.
Why do we include them in the mental health market?
Arab Therapy delivers licensed psychotherapy as a core service, placing the company in virtual therapy and digital mental-health care.
What is the company stage?
Arab Therapy is at the early PMF and expansion stage, with B2C and B2B services already operating across several countries.
How much did they raise?
Arab Therapy raised $2M.
What round is it?
Arab Therapy raised a pre-Series A round.
Why did they raise?
Arab Therapy raised the capital to expand in Saudi Arabia and the broader Middle East while developing its Arabic-first mental-health platform.
Precise Behavioral raised $14.2M in July 2026.
When was it?
Precise Behavioral announced its venture financing on July 29, 2026.
Who are they?
Precise Behavioral provides psychiatrist-led behavioral-health services for hospitals and other institutions through virtual, in-person and technology-supported care.
Geographical focus?
Precise Behavioral primarily serves healthcare organizations in the United States.
Why do we include them in the mental health market?
Precise Behavioral directly delivers psychiatric care and supports its clinical management, placing the company in enterprise behavioral-health services and psychiatry.
What is the company stage?
Precise Behavioral is at the profitable growth stage and was already generating profits when the financing was announced.
How much did they raise?
Precise Behavioral raised $14.2M.
What round is it?
Precise Behavioral described the financing as venture funding, while market databases commonly classify it as a Series A.
Why did they raise?
Precise Behavioral raised the capital to scale operations, deepen health-system partnerships and expand its software and AI capabilities.
Flourish Health raised $26M in July 2026.
When was it?
Flourish Health announced its Series A on July 27, 2026.
Who are they?
Flourish Health delivers intensive psychiatrist-led treatment at home for children and young adults with serious or complex mental-health conditions.
Geographical focus?
Flourish Health operates in the United States and is planning broader national expansion through health-plan partnerships.
Why do we include them in the mental health market?
Flourish Health directly treats high-acuity psychiatric conditions, placing the company in youth mental-health and intensive home-based psychiatric care.
What is the company stage?
Flourish Health is at the PMF and growth stage, with payer relationships, patient outcomes and demand supporting broader expansion.
How much did they raise?
Flourish Health raised $26M in new Series A capital.
What round is it?
Flourish Health raised a Series A round.
Why did they raise?
Flourish Health raised the capital to expand nationally, hire more clinical teams, deepen payer partnerships and build its care technology.
In our report covering the mental health market, we look at what the winners do differently, so you can learn from the best instead of guessing.
Draig Therapeutics raised $65M in July 2026.
When was it?
Draig Therapeutics announced its Series B on July 14, 2026.
Who are they?
Draig Therapeutics develops neuropsychiatric medicines that target AMPA and GABA-A receptors, including a Phase II candidate for major depressive disorder.
Geographical focus?
Draig Therapeutics operates across the UK and U.S. while developing medicines for the global pharmaceutical market.
Why do we include them in the mental health market?
Draig Therapeutics develops medicines specifically for psychiatric disorders, placing the company in neuropsychiatric biotech and psychiatric drug development.
What is the company stage?
Draig Therapeutics is at the clinical stage, with its lead program already in Phase II development.
How much did they raise?
Draig Therapeutics raised $65M.
What round is it?
Draig Therapeutics raised a Series B round.
Why did they raise?
Draig Therapeutics raised the capital to advance its major depressive disorder program and accelerate additional neuropsychiatric medicines toward clinical development.
Handspring Health raised $19M in July 2026.
When was it?
Handspring Health formally announced its Series B on July 8, 2026.
Who are they?
Handspring Health is a virtual mental-health clinic providing evidence-based psychotherapy to children, adolescents and young adults.
Geographical focus?
Handspring Health focuses on patients and families across the United States.
Why do we include them in the mental health market?
Handspring Health uses licensed clinicians to treat diagnosed conditions including anxiety, depression, OCD, ADHD and trauma, placing it in youth virtual therapy.
What is the company stage?
Handspring Health is at the growth stage, with thousands of families served and strong revenue growth before the financing.
How much did they raise?
Handspring Health raised $19M.
What round is it?
Handspring Health raised a Series B round.
Why did they raise?
Handspring Health raised the capital to hire clinicians, expand geographic coverage, grow payer partnerships and strengthen its Complex Care and technology platforms.
Theory only gets you so far. In our research about mental health care, we dig up the real signals from the field and show you the ones worth watching.
Written by the New Market Pitch teamWe track new markets so founders and investors can move faster. About us
